Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma


Sozen H., Ciftci R., Vatansever D., Topuz S., Iyibozkurt A. C., Bozbey H. U., ...Daha Fazla

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, cilt.56, sa.2, ss.199-206, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 56 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1111/ajo.12449
  • Dergi Adı: AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.199-206
  • Anahtar Kelimeler: chemotherapy, endometrial carcinosarcoma, radiotherapy, type II endometrial cancer, PAPILLARY SEROUS CARCINOMA, MIXED MULLERIAN TUMORS, UTERINE, UTERUS, OUTCOMES, THERAPY, COHORT
  • İstanbul Üniversitesi Adresli: Evet

Özet

AimsThe aim of this study was to describe the impact of postoperative adjuvant treatment modalities and identify risk factors associated with recurrence and survival rates in women diagnosed with early stage type II endometrial cancer and carcinosarcoma.